Clinical trial

Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

NCT00283283 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed

Key facts

NCT number NCT00283283
Title Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine
Official title Clinical Study to Compare the Immune Response of Half Dose Trivalent Inactivated Influenza Vaccine (TIV) to Full Dose
Lead sponsor U.S. Army Medical Research and Development Command, U.S. Fed
Collaborators Walter Reed Army Medical Center U.S. Fed United States Army Medical Materiel Development Activity Centers for Disease Control and Prevention Uniformed Services University of the Health Sciences Walter…
Status Completed
Phase Phase 2
Study type Interventional
Conditions Influenza
Intervention type Biological
Interventions Fluzone® (Aventis Pasteur inactivated influenza vaccine)
Enrollment 1,316
Start date Nov 1, 2004
Primary completion Nov 1, 2004
Completion May 1, 2006
First posted Jan 27, 2006
Last update posted Feb 12, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies